Penile cancer remains a relatively infrequent malignancy in North America, Europe, and Asia nevertheless it is a devastating disease which portends an adverse prognosis in those presenting with advanced disease. Similarly, the clinical and surgical care remains highly diverse across many parts of the world often applying non-evidence based approaches in their management.
Guest Editors (From left to right)
Philippe E. Spiess, MD, MS, FACS
Professor of Genitourinary Oncology and Tumor Biology, Assistant Chief of Surgery, Moffitt Cancer Center, Tampa, FL, USA
Michael A. Poch, MD
Assistant Professor, Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA